Regulatory briefing

Our regulatory briefings section delivers current and up-to-date legal and regulatory news relating to all aspects of the CBD industry. It covers individual regulation changes across the world, policy and governmental changes that impact the industry and technological and medical innovations that affect how the industry is regulated, to name a few.

Opponents unlikely to derail Arizona recreational cannabis legalisation

Written by Anthony Traurig || 20th November 2020 || Regulatory briefing |

Arizona
North America
United States
Regulation and Legislation
Regulatory briefing
Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear...

Ukraine moves towards potential medical cannabis legalisation

Written by CBD-Intel || 13th November 2020 || Regulatory briefing |

Europe
Ukraine
Regulation and Legislation
Regulatory briefing
Ukraine has undergone a quick shift in opinion on medical cannabis – proceeding from a point where liberalisation of current laws was viewed as unlikely to setting up parliamentary working groups to draft a bill on legalisation ...

CBD and hemp regulation: confusion in the US

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
Regulation of CBD at the federal level remains confusingly divided between multiple agencies. Three main bodies have overall control of most aspects of hemp and CBD consumer product regulation ...

CBD and hemp regulation: the US DEA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
The passage of the 2018 Farm Bill removed hemp and compounds derived from hemp (including CBD) from the CSA. Therefore, the DEA should have very little involvement in enforcing laws and regulations on hemp and CBD ...

CBD and hemp regulation: the US FDA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
The US Food and Drug Administration (FDA) is a critical agency in the regulatory scheme of CBD products. The 2018 Farm Bill, which legalised hemp and CBD derived from it, granted the FDA the authority to regulate hemp...

CBD and hemp regulation: the USDA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
Among the most important obligations delegated to it in the Farm Bill, the USDA is responsible for rule making regarding production and testing of hemp and approving state and tribal plans for hemp production ...

ACI consortium approach to obtain safety data for CBD moves forward

Written by Freddie Dawson || 25th September 2020 || Regulatory briefing |

EU
Europe
United Kingdom
Science
Technology and Innovation
Regulatory briefing
The Association for the Cannabinoid Industry (ACI) will move forward with its consortium approach to obtaining toxicology and safety data for CBD with at least 15 companies having signed up and an undisclosed number still in discussion ...

Draft guidance on CBD enforcement submitted to OMB for review

Written by CBD-Intel || 3rd August 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups ...

EIHA launches novel food application consortium project

Written by Freddie Dawson || 26th June 2020 || Regulatory briefing |

EU
Europe
EU regulation
Food
Regulation and Legislation
Regulatory briefing
A new consortium project from the EIHA will put four separate novel food applications in to European and UK authorities after performing the necessary toxicological and safety studies ...